Orca Capital AG's Schedule 13G Filing for Co-Diagnostics, Inc.

Orca Capital AG, a German entity, has filed a Schedule 13G with the SEC, disclosing its ownership of 4,809,500 shares of Co-Diagnostics, Inc.'s common stock, representing 9.9% of the total outstanding shares. The filing indicates that Orca Capital AG has sole voting and dispositive power over these shares. The shares were not acquired for the purpose of influencing the control of Co-Diagnostics, Inc. The filing is made pursuant to Rule 13d-1(c) and includes a certification that the shares were not acquired to change or influence the control of the issuer.